tirzepatide patent expiry The Heavy Price of GLP-1 Drugs – I-MAK When do the MOUNJARO patents

If youve been using an injectable GLP-1 like Wegovy and are interested in switching, GoodRx, a platform for medication savings, shares what you need to know to make the transition as smooth as possible

A meta-analysis has indeed highlighted that only about 5060% of patients with diabetes adhere to antidiabetic therapy [69], with a significant impact on quality of life and life expectancy

if pancreatitis is suspected, do not take any further doses and seek urgent medical assessment immediately [15] [16] Pain in the upper right abdomen, or yellowing of the skin or whites of the eyes (jaundice) these may indicate gallbladder disease, a risk associated with rapid weight loss and GLP-1 receptor agonist use [16] [17] Fever accompanying diarrhoea, which may suggest an infective cause requiring separate investigation Significant unintentional weight loss beyond what is expected from the treatment For people with type 2 diabetes: persistent diarrhoea can reduce carbohydrate absorption and increase the risk of hypoglycaemia, particularly if insulin or sulphonylureas are co-prescribed

Both medications must be prescribed within specialist weight management services, typically for a maximum duration of two years, and with regular reviews of effectiveness

We coordinate with pharmacies for convenient at-home delivery

If side effects become severepersistent vomiting, extreme fatigue, or severe abdominal paincontact your healthcare provider immediately